Study title: Pharmacokinetics of a sigle oral dose of pantoprazole 20 mg or 40 mg in pediatric patients aged 5 to 16 years ; safety an tolarability. Open label, randomized, age-stratified, parallel-group study.
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Digestive System Diseases | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: PANTOPRAZOLE | |||||
| ATC code: A02BC02 | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: 3001A1-109-US | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | Y | |